Novartis Ag (NVSEF) Assets Average (2009 - 2010)
Novartis Ag (NVSEF) posted Assets Average of $47897547.8 billion for Q1 2010, up 100303553.78% sequentially from $47.8 billion in Q4 2009, and up 122861356041694.06% YoY from N/an in Q1 2009.
Novartis Ag (NVSEF) Assets Average (2009 - 2010) Analysis & Trends
Novartis Ag (NVSEF) has 2 years of Assets Average data on file, last reported at $47897547.8 billion in Q1 2010.
- Quarterly Assets Average rose 122861356041694.06% year-over-year to $47897547.8 billion in Q1 2010, while the trailing twelve-month figure through Mar 2010 was $47897547.8 billion (up 122861356041694.06% YoY) and the FY2025 annual result came in at $106.6 billion, up 5.44% from the prior year.
- Assets Average climbed to $47897547.8 billion in Q1 2010 per NVSEF's latest filing, from $47.8 billion in the prior quarter.
- The five-year high for Assets Average was $47897547.8 billion in Q1 2010, with the low at $38985.0 in Q1 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 114.53 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 200.05 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 135.21 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 114.04 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 132.78 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 91.55 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 57.65 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 208.08 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Novartis Ag | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | 47,897,500.00 Bn |
| Dec 31, 2009 | 45.34 Bn |
| Sep 30, 2009 | 87.48 Bn |
| Jun 30, 2009 | 81.12 Bn |
| Mar 31, 2009 | 38.99 Bn |